Want to see JP:4918 full AI Analyst Report?
Ivy Cosmetics Corporation (4918) AI Stock Analysis
Ivy Cosmetics Corporation
(TSE/TYO:4918)
The company's fortress-like balance sheet and attractive valuation, featuring a low P/E and high dividend yield, are the primary drivers of the score. These strengths are partially offset by a weak technical trend and significant concerns over revenue volatility and a declining top line.
Ivy Cosmetics Corporation (4918) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 1.74B
- Dividend Yield
- 4.97%
- Average Volume (3M)
- 25.55K
- Price to Earnings (P/E)
- 8.9
- Beta (1Y)
- 0.58
- Revenue Growth
- -6.17%
- EPS Growth
- -55.84%
- Country
- Japan
- Employees
- 179
- Sector
- General
- Sector Strength
- 55
- Industry
- Household & Personal Products
Ivy Cosmetics Corporation Business Overview & Revenue Model
Company Description
Ivy Cosmetics Corporation manufactures and distributes a comprehensive array of cosmetic products and beauty-enhancing supplements. Their extensive catalog includes fundamental skincare items like deep-penetrating beauty liquids, various lotions, emu...
Ivy Cosmetics Corporation Financial Statement Overview
Summary
The balance sheet is a key strength with very low leverage (D/E 0.11) and a solid equity base. Cash flow generation is healthy and consistent. However, revenue volatility and a declining top-line trend weigh on the overall financial picture, offsetting the strong capital structure.
Income Statement
55NeutralBalance Sheet
85Very PositiveCash Flow
72Positive| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.64B | 2.93B | 2.71B | 2.94B | 3.53B |
| Gross Profit | 1.84B | 2.07B | 1.91B | 2.11B | 2.42B |
| EBITDA | 236.31M | 20.62M | 242.60M | -33.16M | 185.13M |
| Net Income | 164.53M | 43.01M | 160.31M | -384.61M | 40.38M |
Balance Sheet | |||||
| Total Assets | 3.64B | 3.57B | 3.57B | 3.85B | 4.49B |
| Cash, Cash Equivalents and Short-Term Investments | 1.04B | 577.94M | 208.73M | 247.67M | 129.38M |
| Total Debt | 278.01M | 211.34M | 451.69M | 1.05B | 1.18B |
| Total Liabilities | 1.00B | 1.10B | 1.33B | 1.87B | 2.22B |
| Stockholders Equity | 2.64B | 2.47B | 2.24B | 1.98B | 2.27B |
Cash Flow | |||||
| Free Cash Flow | 385.37M | 424.68M | 408.70M | 243.33M | -160.58M |
| Operating Cash Flow | 451.04M | 445.94M | 453.06M | 278.59M | -107.06M |
| Investing Cash Flow | -58.15M | -18.43M | 7.30M | -29.30M | 63.30M |
| Financing Cash Flow | 70.61M | -58.27M | -499.31M | -131.00M | 59.71M |
Ivy Cosmetics Corporation Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4918, the sentiment is Negative. The current price of 298.00 is below the 20-day moving average (MA) of 306.35, below the 50-day MA of 301.72, and below the 200-day MA of 322.93, indicating a neutral trend. The MACD of 0.30 indicates Positive momentum. The RSI at 47.63 is Neutral, neither overbought nor oversold. The STOCH value of 21.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4918.
Ivy Cosmetics Corporation Peers Comparison
Overall Rating
JP:492580Outperform- JP:491868Neutral
JP:492065Neutral
JP:492665Neutral
JP:492958.5Neutral
JP:493453Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:4925 | 80Outperform | JPY 6.32B | 9.28 | ― | 2.39% | 0.16% | 6.35% |
| JP:4918 | 68Neutral | JPY 1.71B | 8.86 | ― | 4.97% | -6.17% | -55.84% |
| JP:4920 | 65Neutral | JPY 2.32B | 8.64 | ― | 2.71% | 9.96% | 2053.18% |
| JP:4926 | 65Neutral | JPY 5.30B | 28.91 | ― | 1.61% | 3.17% | -27.27% |
| JP:4929 | 59Neutral | JPY 5.92B | 36.98 | ― | 1.63% | -1.71% | 314.83% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| JP:4934 | 53Neutral | JPY 4.86B | 13.34 | ― | ― | -14.09% | -22.72% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4918 | Ivy Cosmetics Corporation | 302.00 | -16.81 | -5.27% | |
| JP:4920 | Nippon Shikizai, Inc. | 1106.00 | 61.38 | 5.88% | |
| JP:4925 | HABA Laboratories, Inc. | 1671.00 | 46.91 | 2.89% | |
| JP:4926 | C'BON COSMETICS Co., Ltd. | 1239.00 | 66.27 | 5.65% | |
| JP:4929 | ADJUVANT HOLDINGS CO., LTD. | 737.00 | -9.88 | -1.32% | |
| JP:4934 | Premier Anti-Aging Co., Ltd. | 557.00 | -150.00 | -21.22% |
Ivy Cosmetics Corporation Corporate Events
IVY Cosmetics Posts Strong Sales Rebound but Stays in the Red
IVY Cosmetics Corporation reported a 29.5% year-on-year increase in net sales to ¥295 million for the quarter ended June 2026, reversing the prior year’s sales decline but remaining loss-making, with an operating loss of ¥238 million...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 03, 2026